| 000 | 01656 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515054822.0 | ||
| 264 | 0 | _c20070327 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1543-8384 | ||
| 024 | 7 |
_a10.1021/mp060075v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBattisti, Robert F | |
| 245 | 0 | 0 |
_aModifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. _h[electronic resource] |
| 260 |
_bMolecular pharmaceutics _c |
||
| 300 |
_a140-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xchemistry |
| 650 | 0 | 4 |
_aBacterial Proteins _xchemistry |
| 650 | 0 | 4 | _aCarbohydrate Metabolism |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 |
_aDaunorubicin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDisaccharides _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aMonosaccharides _xmetabolism |
| 650 | 0 | 4 | _aProtein Structure, Secondary |
| 700 | 1 | _aZhong, Yanqiang | |
| 700 | 1 | _aFang, Lanyan | |
| 700 | 1 | _aGibbs, Seth | |
| 700 | 1 | _aShen, Jie | |
| 700 | 1 | _aNadas, Janos | |
| 700 | 1 | _aZhang, Guisheng | |
| 700 | 1 | _aSun, Duxin | |
| 773 | 0 |
_tMolecular pharmaceutics _gvol. 4 _gno. 1 _gp. 140-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/mp060075v _zAvailable from publisher's website |
| 999 |
_c16835406 _d16835406 |
||